Go Pro
NASDAQ:YI

111 (YI) Stock Price, News & Analysis

111 logo
$3.22 -0.09 (-2.72%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$3.22 0.00 (0.00%)
As of 10/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About 111 Stock (NASDAQ:YI)

Advanced

Key Stats

Today's Range
$3.21
▼
$3.57
50-Day Range
$3.13
▼
$3.91
52-Week Range
$2.48
▼
$11.17
Volume
15,477 shs
Average Volume
18,410 shs
Market Capitalization
$28.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

111, Inc. is a China-based digital healthcare company that operates an online platform connecting consumers, pharmacies, hospitals, pharmaceutical manufacturers and other healthcare participants. The company focuses on improving access to medicines and healthcare products through technology-enabled distribution and retail services.

Its business includes online sales and distribution of prescription and over-the-counter medicines, medical devices, nutritional products and other healthcare merchandise. 111 also provides business-to-business services that help pharmacies and medical institutions source products, manage inventory and access digital tools, while its consumer-facing operations offer online medicine and healthcare product purchasing.

Founded in 2010 and headquartered in Shanghai, 111 primarily serves the Chinese market. The company was established by Junling Liu, who has served as its chief executive officer and chairman. Its American depositary shares trade on the Nasdaq Global Market under the symbol YI.

AI Generated. May Contain Errors.

111 Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

YI MarketRank™: 

111 scored higher than 11% of companies evaluated by MarketBeat, and ranked 837th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    111 has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    111 has only been the subject of 1 research reports in the past 90 days.

  • Read more about 111's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 111 is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 111 is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about 111's valuation and earnings.
  • Percentage of Shares Shorted

    0.22% of the float of 111 has been sold short.
  • Short Interest Ratio / Days to Cover

    111 has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 111 has recently increased by 11.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    111 does not currently pay a dividend.

  • Dividend Growth

    111 does not have a long track record of dividend growth.

  • News Sentiment

    111 has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for 111 this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 111 insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,782.00 in company stock.

  • Percentage Held by Insiders

    43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    21.32% of the stock of 111 is held by institutions.

  • Read more about 111's insider trading history.
Receive YI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 111 and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YI Stock News Headlines

Comparing Option Care Health (NASDAQ:OPCH) & 111 (NASDAQ:YI)
111, Inc. Announces Establishment of Special Committee
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
111, Inc. Announces Establishment of the Special Committee
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
See More Headlines

YI Stock Analysis - Frequently Asked Questions

111's stock was trading at $2.56 at the start of the year. Since then, YI stock has increased by 25.8% and is now trading at $3.22.

111, Inc. Sponsored ADR (NASDAQ:YI) announced its earnings results on Friday, September, 18th. The company reported ($0.60) earnings per share (EPS) for the quarter. The business earned $338.55 million during the quarter.

Shares of 111 reverse split before market open on Friday, January 24th 2025.The 1-10 reverse split was announced on Wednesday, January 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

111 (YI) raised $108 million in an initial public offering on Wednesday, September 12th 2018. The company issued 7,175,000 shares at $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC acted as the underwriters for the IPO.

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Twilio (TWLO).

Company Calendar

Last Earnings
9/18/2026
Today
10/03/2026
Next Earnings (Estimated)
11/26/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:YI
CIK
1738906
Fax
N/A
Employees
1,063
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.65 million
Net Margins
-1.01%
Pretax Margin
-0.38%
Return on Equity
N/A
Return on Assets
-4.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.08
Quick Ratio
0.49

Sales & Book Value

Annual Sales
$1.80 billion
Price / Sales
0.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($11.74) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
8,790,000
Free Float
4,928,000
Market Cap
$28.30 million
Optionable
Optionable
Beta
0.67
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:YI) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners